Angel Round - AceRNA
Investment Firm
Overview
AceRNA specializes in the development of patient-centric novel genetic therapies based on evidence-based drug-discovery process.
Announced Date
Jan 01, 2020
Funding Type
Angel
Highlights
Location
Asia
Social
Investor Lead
N/A
Participant Investors
2
| Investor Name |
|---|
Round Details and Background
AceRNA raised an undisclosed amount on 2020-01-01 in Angel Round
AceRNA specializes in the development of patient-centric novel genetic therapies based on evidence-based drug-discovery process.
Company Funding History
3
| Announcment Date | Transaction Name | Number Of Investors | Lead Investor | Money Raised |
|---|---|---|---|---|
| Nov 09, 2018 |  Seed Round - AceRNA | 1 | - | 702.8K |
| Oct 31, 2019 | Series A - AceRNA | 2 | - | 1.9M |
| Jan 01, 2020 | Angel Round - AceRNA | 2 | - | undefined |
Recent Activity
There is no recent news or activity for this profile.